Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 3 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Cash flows from operating activities:    
Net income $ 397,112 $ 244,006
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization expense 95,813 104,786
Compensatory element of stock options 152,236 89,948
Provision for doubtful accounts 161,891 86,135
Equity in losses of affiliate 113,575 38,450
Changes in assets and liabilities:    
Accounts receivable (529,649) (36,759)
Notes receivable 550,782 139,051
Prepaid expenses and other current assets 77,758 108,604
Deposits and other assets, net 42,628 7,999
Accounts payable 231,176 234,994
Accrued expenses (713,994) (320,401)
Deferred revenue (686,024) (191,138)
Net cash (used in) provided by operating activities (106,696) 505,675
Cash flows from investing activities:    
Release of restricted cash held in escrow 24,166 28,719
Purchases of property and equipment (11,025) (77,293)
Purchases of marketable securities and other investments (61,685)  
Investments in patents   (28,382)
Investment in affiliate (75,000)  
Net cash used in investing activities (123,544) (76,956)
Cash flows from financing activities:    
Treasury stock purchases (451,913) (247,045)
Net cash used in financing activities (451,913) (247,045)
(Decrease) increase in cash and cash equivalents (682,153) 181,674
Cash and cash equivalents - beginning of period 3,925,156 2,677,382
Cash and cash equivalents - end of period $ 3,243,003 $ 2,859,056